Frovatriptan

CHEMBL1279 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

243.3 g/mol

LogP

1.2

Phase

4

This triptan medication treats acute migraine attacks by activating serotonin receptors in the brain to constrict blood vessels and block pain signals involved in migraines. It has a longer half-life than some other triptans, which may make it useful for migraines that tend to recur.

分子量

243.3000 g/mol

LogP

1.20

TPSA

70.90 Å²

リピンスキーの五則

適合

治療領域

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Migraine Multiple Sclerosis Stroke Type 2 Diabetes Hypertension Breast Cancer Chronic Pain Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1

InChI

InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1

Molecular Formula

C14H17N3O

HBD / HBA

3 / 2

回転可能結合数

2

重原子数

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This triptan medication treats acute migraine attacks by activating serotonin receptors in the brain to constrict blood vessels and block pain signals involved in migraines. It has a longer half-life than some other triptans, which may make it useful for migraines that tend to recur.

Yes, Frovatriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1279. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 77992. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Frovatriptan PillFYIで

構造

クイックデータ

分子式: C14H17N3O
同義語: 1

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.